Besides ibrutinib, patients with M-CLL, devoid of TP53 aberrations and in shape plenty of to tolerate FCR therapy, should be good candidates for the latter, Using the advantage becoming this procedure is usually done in six months although ibrutinib has to be taken indefinitely. This option could well be significantly precious for non-compliant suf… Read More